Analysts say Pfizer could use its strong connections within the Trump administration to bolster its case, with CEO Albert ...

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...

The pharmaceutical sector is witnessing a high-stakes confrontation as Pfizer finds itself embroiled in a fierce bidding ...

Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.

AbbVie dipped early Friday, though the drug giant easily beat third-quarter forecasts on the back of its immunology meds.